-
1
The Need for Inducing Tolerance in Vascularized Composite Allotransplantation
Published 2012-01-01“…Successful hand and face transplantation in the last decade has firmly established the field of vascularized composite allotransplantation (VCA). The experience in VCA has thus far been very similar to solid organ transplantation in terms of the morbidity associated with long-term immunosuppression. …”
Get full text
Article -
2
Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation
Published 2012-01-01“…Vascularized composite allotransplantations (VCAs) are not routinely performed for tissue reconstruction because of the potentially harmful adverse effects associated with lifelong administration of immunosuppressive agents. …”
Get full text
Article -
3
Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential
Published 2013-01-01Get full text
Article -
4
Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation
Published 2013-01-01“…The emerging field of vascular composite allotransplantation (VCA) has become a clinical reality. …”
Get full text
Article -
5
Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation
Published 2016-01-01“…Despite recent progress in vascularized composite allotransplantation (VCA), limitations including complex, high dose immunosuppression regimens, lifelong risk of toxicity from immunosuppressants, acute and most critically chronic graft rejection, and suboptimal nerve regeneration remain particularly challenging obstacles restricting clinical progress. …”
Get full text
Article -
6
Mechanisms and Mediators of Inflammation: Potential Models for Skin Rejection and Targeted Therapy in Vascularized Composite Allotransplantation
Published 2012-01-01“…Vascularized composite allotransplantation (VCA) is an effective treatment option for patients suffering from limb loss or severe disfigurement. …”
Get full text
Article -
7
The Role of Imaging in Patient Selection, Preoperative Planning, and Postoperative Monitoring in Human Upper Extremity Allotransplantation
Published 2014-01-01“…To describe the role of imaging in vascular composite allotransplantation based on one institution’s experience with upper extremity allotransplant patients. …”
Get full text
Article -
8
Multi-Center Outcome Analysis of 16 Face Transplantations – A Retrospective OPTN Study
Published 2025-01-01Subjects: “…vascularized composite allotransplantation…”
Get full text
Article -
9
Immune responses in rodent whole eye transplantation: elucidation and preliminary investigations into rejection diagnosis and monitoring
Published 2025-01-01Subjects: “…vascularized composite allotransplantation…”
Get full text
Article -
10
Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody
Published 2018-01-01“…A 41-year-old male with severe disfigurement from facial burns consented to facial allotransplantation in 2014; panel reactive antibody score was 0%. …”
Get full text
Article -
11
Cryptococcal cerebrospinal fluid shunt infection treated with fluconazole
Published 1993-01-01“…A 37-year-old woman with a cadaveric renal allotransplantation required intra-cranial shunting devices after a presumptive episode of tuberculous meningitis. …”
Get full text
Article -
12
Regulatory Immunotherapy in Bone Marrow Transplantation
Published 2011-01-01“…The immunobiology of allotransplantation is an area of ongoing discovery, from the recipient's conditioning treatment prior to the transplant to the donor cell populations responsible for engraftment, graft-versus-host disease, and graft-versus-tumor effect. …”
Get full text
Article -
13
Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies
Published 2019-01-01Get full text
Article -
14
Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis
Published 2012-01-01Get full text
Article -
15
Self-Centered Function of Adaptive Immunity in Regulation of Immune Responses and in Tolerance
Published 2021-01-01“…Described are clinically identified conditions for operational tolerance of MHC-disparate tissues/living systems in allotransplantation, which are in line with the CDR-proposed self-centered regulatory role of T/B cells. …”
Get full text
Article -
16
Deceased Donor Renal Transplantation Combined with Bilateral Nephrectomy in a Patient with Tuberous Sclerosis and Renal Failure
Published 2019-01-01“…Based on the “kidney transplant waiting list” order patient underwent a bilateral nephrectomy combined with transperitoneal renal allotransplantation of a cadaverous kidney graft through midline laparotomy, appendectomy, and cholecystectomy. …”
Get full text
Article -
17
Morphological aspects of cell-based reconstruction of rectal mucosa at surgical treatment of familial adenomatosis coli
Published 2013-12-01“…For reconstruction of mucosa of the rectum cell-based allotransplantation was applied. Morphological mechanisms of mucosal reparation were investigated in 34 FAC patients (main and control groups).Results. …”
Get full text
Article -
18
Transplant Tolerance: New Insights and Strategies for Long-Term Allograft Acceptance
Published 2013-01-01“…To solve this setback in allotransplantation, researchers have focused on manipulating the immune response in order to create a state of tolerance rather than unspecific immunosuppression. …”
Get full text
Article -
19
Computational pathology assessments of cardiac stromal remodeling: Clinical correlates and prognostic implications in heart transplantation
Published 2025-02-01“…Background: The hostile immune environment created by allotransplantation can accelerate pathologic tissue remodeling. …”
Get full text
Article -
20
Contextual Vulnerability Should Guide Fair Subject Selection in Xenotransplantation Clinical Trials
Published 2023-03-01“…Enrolling research subjects subjectively excluded from allotransplantation into xenotransplant research is not a mechanism of fair access but rather an exploitation of an unjustly option-constrained vulnerable group by the clinical transplant system. …”
Get full text
Article